SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 114 filers reported holding SEELOS THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $215,000 | -46.0% | 257,883 | +5.6% | 0.03% | -52.5% |
Q4 2021 | $398,000 | -32.4% | 244,171 | 0.0% | 0.06% | +43.9% |
Q3 2021 | $589,000 | -20.3% | 244,171 | -12.7% | 0.04% | -31.7% |
Q2 2021 | $739,000 | -79.4% | 279,840 | -61.0% | 0.06% | -50.4% |
Q1 2021 | $3,585,000 | – | 718,284 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 508,000 | $249,000 | 0.10% |
1492 Capital Management LLC | 150,000 | $74,000 | 0.09% |
Uniplan Investment Counsel, Inc. | 2,069,121 | $1,014,000 | 0.08% |
ARDSLEY ADVISORY PARTNERS LP | 70,000 | $34,000 | 0.01% |
Spark Investment Management LLC | 35,210 | $17,000 | 0.01% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 191,000 | $94,000 | 0.00% |
WealthPLAN Partners, LLC | 20,000 | $15,000 | 0.00% |
Procyon Advisors, LLC | 2,500 | $1,000 | 0.00% |
Renaissance Technologies | 1,078,379 | $529,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |